These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30392076)

  • 1. The role of CD47 in pathogenesis and treatment of renal ischemia reperfusion injury.
    Isenberg JS; Roberts DD
    Pediatr Nephrol; 2019 Dec; 34(12):2479-2494. PubMed ID: 30392076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondin-1 activation of signal-regulatory protein-α stimulates reactive oxygen species production and promotes renal ischemia reperfusion injury.
    Yao M; Rogers NM; Csányi G; Rodriguez AI; Ross MA; St Croix C; Knupp H; Novelli EM; Thomson AW; Pagano PJ; Isenberg JS
    J Am Soc Nephrol; 2014 Jun; 25(6):1171-86. PubMed ID: 24511121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency in SIRP-α cytoplasmic recruitment confers protection from acute kidney injury.
    Ghimire K; Chiba T; Minhas N; Meijles DN; Lu B; O'Connell P; Rogers NM
    FASEB J; 2019 Oct; 33(10):11528-11540. PubMed ID: 31370677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD47 regulates renal tubular epithelial cell self-renewal and proliferation following renal ischemia reperfusion.
    Rogers NM; Zhang ZJ; Wang JJ; Thomson AW; Isenberg JS
    Kidney Int; 2016 Aug; 90(2):334-347. PubMed ID: 27259369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of parenchymal CD47 promotes renal ischemia-reperfusion injury.
    Rogers NM; Thomson AW; Isenberg JS
    J Am Soc Nephrol; 2012 Sep; 23(9):1538-50. PubMed ID: 22859854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is CD47 a potentially promising therapeutic target in cardiovascular diseases? - Role of CD47 in cardiovascular diseases.
    Cheng Q; Gu J; Adhikari BK; Sun L; Sun J
    Life Sci; 2020 Apr; 247():117426. PubMed ID: 32061866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signaling.
    Isenberg JS; Maxhimer JB; Powers P; Tsokos M; Frazier WA; Roberts DD
    Surgery; 2008 Nov; 144(5):752-61. PubMed ID: 19081017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its management.
    Rogers NM; Yao M; Novelli EM; Thomson AW; Roberts DD; Isenberg JS
    Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1117-25. PubMed ID: 22874763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD47 blockade reduces ischemia-reperfusion injury and improves outcomes in a rat kidney transplant model.
    Lin Y; Manning PT; Jia J; Gaut JP; Xiao Z; Capoccia BJ; Chen CC; Hiebsch RR; Upadhya G; Mohanakumar T; Frazier WA; Chapman WC
    Transplantation; 2014 Aug; 98(4):394-401. PubMed ID: 24983310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD47 limits autophagy to promote acute kidney injury.
    El-Rashid M; Ghimire K; Sanganeria B; Lu B; Rogers NM
    FASEB J; 2019 Nov; 33(11):12735-12749. PubMed ID: 31480863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombospondin-1/CD47 blockade following ischemia-reperfusion injury is tissue protective.
    Maxhimer JB; Shih HB; Isenberg JS; Miller TW; Roberts DD
    Plast Reconstr Surg; 2009 Dec; 124(6):1880-1889. PubMed ID: 19952644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potentiating effect of hTFPI in the presence of hCD47 reduces the cytotoxicity of human macrophages.
    Jung SH; Hwang JH; Kim SE; Young Kyu K; Park HC; Lee HT
    Xenotransplantation; 2017 May; 24(3):. PubMed ID: 28393401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD47 blockade alleviates acute rejection of allogeneic mouse liver transplantation by reducing ischemia/reperfusion injury.
    Li DY; Xie SL; Wang GY; Dang XW
    Biomed Pharmacother; 2020 Mar; 123():109793. PubMed ID: 31884341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD47 in the immune response: role of thrombospondin and SIRP-alpha reverse signaling.
    Sarfati M; Fortin G; Raymond M; Susin S
    Curr Drug Targets; 2008 Oct; 9(10):842-50. PubMed ID: 18855618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking thrombospondin-1 signaling via CD47 mitigates renal interstitial fibrosis.
    Julovi SM; Sanganeria B; Minhas N; Ghimire K; Nankivell B; Rogers NM
    Lab Invest; 2020 Sep; 100(9):1184-1196. PubMed ID: 32366943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRPα-CD47 Immune Checkpoint Blockade in Anticancer Therapy.
    Veillette A; Chen J
    Trends Immunol; 2018 Mar; 39(3):173-184. PubMed ID: 29336991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses.
    Isenberg JS; Annis DS; Pendrak ML; Ptaszynska M; Frazier WA; Mosher DF; Roberts DD
    J Biol Chem; 2009 Jan; 284(2):1116-25. PubMed ID: 19004835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the CD47-SIRPα signaling axis: current studies on B-cell lymphoma immunotherapy.
    Zhang J; Jin S; Guo X; Qian W
    J Int Med Res; 2018 Nov; 46(11):4418-4426. PubMed ID: 30226089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathophysiology of ischemia-reperfusion injury in renal transplantation].
    Boratyńska M; Kamińska D; Mazanowska O
    Postepy Hig Med Dosw (Online); 2004 Feb; 58():1-8. PubMed ID: 15069377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major Ozonated Autohemotherapy Preconditioning Ameliorates Kidney Ischemia-Reperfusion Injury.
    Sancak EB; Turkön H; Çukur S; Erimsah S; Akbas A; Gulpinar MT; Toman H; Sahin H; Uzun M
    Inflammation; 2016 Feb; 39(1):209-217. PubMed ID: 26282390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.